Trademarkia Logo

Australia

AU$
ALMIQI
Cancelled: Cancelled at the request of IB

Last updated on 7 Aug 2023

Owner Info

Bioxcel Therapeutics, Inc.

555 Long Wharf Drive, 12th Floor

New Haven CT 06516, UNITED STATES OF AMERICA

Serial Number

2185567 filed on 14 Apr 2021

Correspondent

Brendan J. Hughes Cooley LLP

1299 Pennsylvania Avenue, NW, Suite 700,

Washington DC 20004,

UNITED STATES OF AMERICA

ALMIQI

Classification Information


Class [005]
Pharmaceuticals for the treatment of agitation; pharmaceuticals for the treatment of agitation associated with neuropsychiatric conditions, neurodegen Read More

Mark Details


Serial Number

2185567

Registered On

14 Apr 2021

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

3 Nov 2020

Mark Type

US

Legal History


Show more

Status DateAction Taken
7th Aug 2023Status change to Voided
31st Aug 2021International Registration in Australia Protected correspondence sent
30th Aug 2021IP Right Registration Published
30th Aug 2021Status change to Registered/Protected
22nd Jun 2021Application Accepted correspondence sent
21st Jun 2021IP Right has been Examined
21st Jun 2021IP Right Acceptance Published
21st Jun 2021Status change to Accepted
17th Jun 2021Awaiting examination
17th Jun 2021Examination expedited